TrovaGene, Inc. To Present At 27th Annual Piper Jaffray Healthcare Conference And Attend Evercore ISI Investor Conference

SAN DIEGO, Nov. 25, 2015 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today announced that Chief Executive Officer Antonius Schuh, Ph.D., is scheduled to present a corporate overview at the 27th Annual Piper Jaffray Healthcare Conference.

A molecular diagnostics company with unique intellectual property around the discovery that DNA and RNA, present in urine, can be diagnostic of cancer and infectious disease.

Trovagene is scheduled to present at the 27th Annual Piper Jaffray Healthcare Conference at the New York Palace Hotel in New York on Tuesday, December 1, 2015 at 1:30 p.m. EST. Mr. Schuh will be available for one-on-one meetings during the conference. The presentation will be webcast live at and can also be accessed through the investor relations page at A replay of the presentation will be available at and will be archived for 90 days.

In addition, Trovagene’s Chief Scientific Officer, Mark Erlander, Ph.D., will be available for one on one meetings at the Evercore ISI MedTools and Outsourcing Investor Forum on December 2-3, in Boston, MA.

About Trovagene, Inc.
Headquartered in San Diego, California, Trovagene is leveraging its proprietary technology for the detection and monitoring of cell-free DNA in urine. The Company’s technology detects and quantitates oncogene mutations in cancer patients for improved disease management. Trovagene’s precision cancer monitoring platform is designed to provide important clinical information beyond the current standard of care, and is protected by significant intellectual property including multiple issued patents and pending patent applications globally.


Investor Relations

Media Relations

David Moskowitz and Amy Caterina

Investor Relations

Ian Stone

Account Director

Trovagene, Inc.

Canale Communications, Inc.



Logo -

To view the original version on PR Newswire, visit:

SOURCE Trovagene, Inc.